Nov 7th, 2019: The Biggest Medical Breakthrough in History…

Urgent: Open Immediately November 3, 2019   Nov 7th, 2019: The Biggest Medical Breakthrough in History… Dear Daily Prophecy Reader, Has the stage been set for the biggest medical breakthrough in history? One tiny biotech firm holds the patented technology and PROVEN clinical studies to unleash the news that could change mankind as we know it.  An announcement that as soon as Nov 7th, could send this tiny $6 biotech stock on the single biggest bull-run I've ever seen. So much so, early investors could reap a million-dollar payout when the announcement is made. And even prolific investors like Jeff Bezos (the richest man in the world) is investing $151 million of his money in… And now is your time to get in along with these elite investors… But there's limited time, click below to find out before the announcement's made. Click here now to find out who this tiny biotech firm is… Sincerely, Doug Hill Publisher, Gilder's Daily Prophecy   To end your Gilder's Daily Prophecy e-mail subscription and associated external offers sent from Gilder's Daily Prophecy, click here to unsubscribe. If you are having trouble receiving your Gilder's Daily Prophecy subscription, you can ensure its arrival in your mailbox by whitelisting Gilder's Daily Prophecy. Gilder's Daily Prophecy is committed to protecting and respecting your privacy. Please read our Privacy Statement. Gilder Press, a division of Laissez Faire Books, LLC. 808 Saint Paul Street, Baltimore MD 21202. Nothing in this e-mail should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. © 2019 Gilder Press, a division of Laissez Faire Books, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Gilder Press, a division of Laissez Faire Books, LLC.